M2-Macrophage-Derived Exosomes Promote Meningioma Progression through TGF-β Signaling Pathway.

Area of Science:

• Oncology
• Cell Biology
• Immunology

Background:

• Tumor-associated macrophages (TAMs) are key in the tumor microenvironment, aiding cancer progression.
• The role of TAMs in meningioma development is not fully understood.
• This study investigates M2-polarized macrophage-derived exosomes (M2-MDEs) in meningioma.

Purpose of the Study:

• To explore the role of M2-MDEs in meningioma tumorigenesis and progression.
• To identify the molecular mechanisms by which M2-MDEs influence meningioma cells.
• To assess the therapeutic potential of targeting M2-MDEs.

Main Methods:

• Immunohistochemistry to analyze macrophage phenotypes in meningioma tissues.
• Cell coculture and RNA sequencing to study M2-MDE effects on meningioma cells.
• 3D tumorsphere and xenograft models to evaluate tumorigenesis and development.

Main Results:

• M2 macrophages are abundant in meningioma tissues, and M2-MDEs promote proliferation, migration, and invasion.
• Bioinformatic analysis revealed TGF-β pathway activation in meningioma cells treated with M2-MDEs.
• Inhibition of the TGF-β pathway reversed the tumor-promoting effects of M2-MDEs.

Conclusions:

• M2-MDEs enhance meningioma development and invasion via TGF-β pathway activation.
• Exosome-mediated communication is a potential therapeutic target for meningioma.
• Targeting M2-MDEs could represent a novel strategy for meningioma treatment.